CRSP – CRISPR Therapeutics AG

CRISPR Therapeutics AG

CRSP

$56.68

Name : CRISPR Therapeutics AG

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $5,401,617,408.00

EPSttm : -5.54

CRISPR Therapeutics AG

$56.68

2.43%

$1.41

Float Short %

24.56

Margin Of Safety %

Put/Call OI Ratio

0.43

EPS Next Q Diff

0.08

EPS Last/This Y

-1.86

EPS This/Next Y

1.74

Price

56.76

Target Price

77.84

Analyst Recom

1.97

Performance Q

-2.01

Relative Volume

0.55

Beta

1.69

Ticker: CRSP

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-13	CRSP	51.13	0.47	0.79	135712
2025-11-14	CRSP	52.52	0.47	0.12	136527
2025-11-17	CRSP	55.28	0.46	0.23	133917
2025-11-18	CRSP	53.76	0.46	0.45	140680
2025-11-19	CRSP	50.75	0.47	0.61	142477
2025-11-20	CRSP	49.28	0.47	0.33	142903
2025-11-21	CRSP	50.23	0.45	0.45	142468
2025-11-24	CRSP	51.22	0.45	0.34	117767
2025-11-25	CRSP	53.54	0.45	0.34	122254
2025-11-26	CRSP	53.32	0.45	0.17	124562
2025-12-01	CRSP	52.19	0.45	0.23	121465
2025-12-02	CRSP	51.58	0.45	0.51	123969
2025-12-03	CRSP	56	0.45	0.28	126118
2025-12-04	CRSP	58.17	0.45	0.14	128398
2025-12-05	CRSP	56.86	0.43	0.27	131712
2025-12-08	CRSP	57.36	0.44	0.23	127661
2025-12-09	CRSP	57.03	0.43	0.37	129402
2025-12-10	CRSP	57.57	0.44	0.13	130966
2025-12-11	CRSP	58.1	0.43	0.27	131801
2025-12-12	CRSP	56.66	0.43	0.15	132714
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-13	CRSP	51.18	-177.2	263.8	-6.37
2025-11-14	CRSP	52.56	-177.2	167.7	-6.37
2025-11-17	CRSP	55.27	-166.9	153.7	-6.24
2025-11-18	CRSP	53.53	-169.1	203.2	-6.26
2025-11-19	CRSP	50.73	-169.1	214.1	-6.26
2025-11-20	CRSP	49.29	-169.1	201.7	-6.26
2025-11-21	CRSP	50.22	-176.0	173.0	-6.23
2025-11-24	CRSP	51.21	-176.0	172.9	-6.23
2025-11-25	CRSP	53.57	-175.8	157.5	-6.20
2025-11-26	CRSP	53.29	-175.8	187.6	-6.20
2025-12-01	CRSP	52.17	-178.4	198.9	-6.20
2025-12-02	CRSP	51.58	-178.4	191.4	-6.20
2025-12-03	CRSP	55.99	-178.4	133.9	-6.20
2025-12-04	CRSP	58.18	-178.4	162.3	-6.20
2025-12-05	CRSP	56.88	-178.4	197.2	-6.20
2025-12-08	CRSP	57.36	-178.4	-	-6.20
2025-12-09	CRSP	57.04	-178.4	187.8	-6.20
2025-12-10	CRSP	57.54	-178.4	179.7	-6.20
2025-12-11	CRSP	58.11	-178.4	179.5	-6.20
2025-12-12	CRSP	56.76	-178.4	197.6	-6.20
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-13	CRSP	22.00	10.16	23.34
2025-11-14	CRSP	22.00	10.16	23.17
2025-11-17	CRSP	26.02	6.12	23.17
2025-11-18	CRSP	26.02	6.12	23.17
2025-11-19	CRSP	26.02	6.12	23.17
2025-11-20	CRSP	26.02	6.12	23.17
2025-11-21	CRSP	26.02	6.12	23.17
2025-11-24	CRSP	26.02	1.01	23.03
2025-11-25	CRSP	30.83	1.01	23.03
2025-11-26	CRSP	30.83	1.01	25.39
2025-12-01	CRSP	31.00	1.01	25.39
2025-12-02	CRSP	31.00	1.01	25.39
2025-12-03	CRSP	31.00	1.01	25.39
2025-12-04	CRSP	31.00	1.01	25.39
2025-12-05	CRSP	31.00	1.01	25.39
2025-12-08	CRSP	31.00	0.99	25.39
2025-12-09	CRSP	31.00	0.99	25.39
2025-12-10	CRSP	31.00	0.99	24.56
2025-12-11	CRSP	31.00	0.99	24.56
2025-12-12	CRSP	31.00	0.99	24.56
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

[stock_market_widget type="chart" template="candlestick" assets="CRSP" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

-1.17

Avg. EPS Est. Current Quarter

-1.23

Avg. EPS Est. Next Quarter

-1.09

Insider Transactions

Institutional Transactions

0.99

Beta

1.69

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

74.2

Max Drawdown 5-Year %

-85.1

Target Price

77.84

P/E

Forward P/E

PEG

P/S

140.89

P/B

2.78

P/Free Cash Flow

EPS

-5.58

Average EPS Est. Cur. Y

-6.2

EPS Next Y. (Est.)

-4.46

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-1273.7

Relative Volume

0.55

Return on Equity vs Sector %

-52.4

Return on Equity vs Industry %

-37.4

EPS 1 7Days Diff

EPS 1 30Days Diff

0.06

EBIT Estimation

197.6

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”CRSP” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”CRSP” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”CRSP” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”CRSP” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”CRSP” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”CRSP” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”CRSP” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

CRISPR Therapeutics AG

Sector: Healthcare

Industry: Biotechnology

Employees: 393

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company's CRISPR/Cas9 is a revolutionary technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, CAR T cell therapies, in vivo, and type 1 diabetes, as well as develops investigational CAR T programs, including an autologous, gene-edited CAR T program targeting glypican-3 (GPC3) for the potential treatment of solid tumors. The company's lead product candidate is CASGEVY, an ex vivo CRISPR/Cas9 gene-edited cell therapy for treating patients suffering from transfusion-dependent beta-thalassemia, severe sickle cell disease (SCD), and hemoglobinopathies in which a patient's hematopoietic stem and progenitor cells are edited to produce high levels of fetal hemoglobin in red blood cells. It also develops CAR T cell therapies, including CTX112 targeting cluster of differentiation 19 (CD19) and CTX131 targeting CD70 for oncology and autoimmune indications; CTX310 and CTX320, in vivo gene editing to address the cardiovascular disease by disrupting the validated targets angiopoietin-like protein 3 and lipoprotein; and CTX211, an allogeneic, gene-edited, hypoimmune stem cell-derived product candidate for the treatment of T1D. It has strategic partnerships with Vertex Pharmaceuticals Incorporated, Nkarta, Inc., and Capsida Biotherapeutics. CRISPR Therapeutics AG was incorporated in 2013 and is headquartered in Zug, Switzerland.

stock quote shares CRSP – CRISPR Therapeutics AG Stock Price stock today

news today CRSP – CRISPR Therapeutics AG stock forecast ,stock prediction 2023 2024 2025

marketwatch CRSP – CRISPR Therapeutics AG yahoo finance google finance

stock history CRSP – CRISPR Therapeutics AG invest stock market

stock prices CRSP premarket after hours

ticker CRSP fair value insiders trading

CRSP – CRISPR Therapeutics AG

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: CRSP

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y